Browse by all authors Browse By Author ID - Good, Michael F.

Browse Results (74 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Page 1 of 2

Result Pages:    1 2  next › last »

Refine

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Hirunpetcharat, C., Vukovic, P., Xue, Q. L., Kaslow, D. C., Miller, L. H. and Good, M. F. (1999) Absolute requirement for an active immune response involvingb B cells and TH cells in immunity to plasmodium yoelii passively acquired with antibodies to the 19-KDA carboxyl-terminal fragment of merozoite surface protein-1. Journal of Immunology, 162 12: 7309-7314. 310   58
Wykes, Michelle and Good, Michael F. (2007) A case for whole-parasite malaria vaccines. International Journal for Parasitology, 37 7: 705-712. doi:10.1016/j.ijpara.2007.02.007 87   23 Cited 24 times in Scopus24 0
Good, M. F., Xu, H. J. and Batzloff, M. (2002) Adapting immunity with subunit vaccines: case studies with group A Streptococcus and malaria. International Journal For Parasitology, 32 5: 575-580. doi:10.1016/S0020-7519(01)00360-5 52   6 Cited 6 times in Scopus6 0
Batzloff, Michael R., Pandey, Manisha, Olive, Colleen and Good, Michael F. (2006) Advances in potential M-protein peptide-based vaccines for preventing rheumatic fever and rheumatic heart disease. Immunologic Research, 35 3: 233-248. doi:10.1385/IR:35:3:233 47   15 Cited 13 times in Scopus13 0
Horvath, Aniko, Olive, Colleen, Wong, Allan, Clair, Timothy, Yarwood, Penny, Good, Michael and Toth, Istvan (2001) A lipophilic adjuvant carrier system for antigenic peptides. Letters in Peptide Science, 8 3-5: 285-288. doi:10.1007/BF02446530 67   9 Cited 17 times in Scopus17 0
Toth, I., Horvath, A., Good, M. F. and Olive, C. (2002). A multiple antigen lipophilic adjuvant carrier system (MALAC). Australian Provisional PS2233. 80  
Trenholme, Katharine R., Boutlis, Craig S., Kuns, Rachel, Lagog, Moses, Bockarie, Moses J., Gatton, Michelle L., Kemp, David J., Good, Michael F., Anstey, Nicholas M. and Gardiner, Donald L. (2005) Antibody reactivity to linear epitopes of Plasmodium falciparum cytoadherence-linked asexual gene 9 in asymptomatic children and adults from Papua New Guinea. American Journal of Tropical Medicine and Hygiene, 72 6: 708-713. 83   8 Cited 9 times in Scopus9
Wipasa, Jiraprapa, Xu, Huji, Stowers, Anthony and Good, Michael F. (2001) Apoptotic deletion of Th cells specific for the 19-kDa carboxyl-terminal fragment of merozoite surface protein 1 during malaria infection. Journal of Immunology, 167 7: 3903-3909. 54   50 Cited 55 times in Scopus55
Amante, Fiona H., Stanley, Amanda C., Randall, Louise M., Zhou, Yonghong, Haque, Ashraful, McSweeney, Karli, Waters, Andrew P., Janse, Chris J., Good, Michael F., Hill, Geoff R. and Engwerda, Christian R. (2007) A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria. American Journal of Pathology, 171 2: 548-559. doi:10.2353/ajpath.2007.061033 112   81 Cited 88 times in Scopus88 0
Pender, M. P., Csurhes, P. A., Houghten, R. A., McCombe, P. A. and Good, M. F. (1996) A Study Of Human T-Cell Lines Generated From Multiple Sclerosis Patients And Controls By Stimulation With Peptides Of Myelin Basic Protein. Journal of Neuroimmunology, 70 1: 65-74. doi:10.1016/S0165-5728(96)00105-1 624 246 13 Cited 13 times in Scopus13 0
Pender, M. P., Csurhes, P. A., Houghten, R. A., McCombe, P. A. and Good, M. F. (1997) Corrigendum to "A Study Of Human T-Cell Lines Generated From Multiple Sclerosis Patients And Controls By Stimulation With Peptides Of Myelin Basic Protein" (J. Neuroimmunol. 70, 65-74). Journal of Neuroimmunology, 73 1-2: 213-213. 285 96 0
Wykes, Michelle, Keighley, Caitlin, Pinzon-Charry, Alberto and Good, Michael F. (2007) Dendritic cell biology during malaria. Cellular Microbiology, 9 2: 300-305. doi:10.1111/j.1462-5822.2006.00865.x 34   15 Cited 14 times in Scopus14 0
Abdel-Aal, Abu-Baker M., Zaman, Mehfuz, Fujita, Yoshio, Batzloff, Michael R., Good, Michael F. and Toth, Istvan (2010) Design of three-component vaccines against group A streptococcal infections: Importance of spatial arrangement of vaccine components. Journal of Medical Chemistry, 53 22: 8041-8046. doi:10.1021/jm1007787 76   11 Cited 15 times in Scopus15 0
Good, Michael F., Xu, Huji, Wykes, Michelle and Engwerda, Christian R. (2005) Development and regulation of cell-mediated immune responses to the blood stages of malaria: Implications for vaccine research. Annual Review of Immunology, 23 66-69. doi:10.1146/annurev.immunol.23.021704.115638 57   107 Cited 114 times in Scopus114 0
Simerska, Pavla, Abdel-Aal, Abu-Baker M., Fujita, Yoshio, Moyle, Peter M., McGeary, Ross P., Batzloff, Michael R., Olive, Colleen, Good, Michael F. and Toth, Istvan (2008) Development of a liposaccharide-based delivery system and its application to the design of Group A streptococcal vaccines. Journal of Medicinal Chemistry, 51 5: 1447-1452. doi:10.1021/jm701410p 91   20 Cited 22 times in Scopus22 0
Zhong, Wei, Skwarczynski, Mariusz, Simerska, Pavla, Good, Michael F. and Toth, Istvan (2009) Development of highly pure alpha-helical lipoglycopeptides as self-adjuvanting vaccines. Tetrahedron, 65 17: 3459-3464. doi:10.1016/j.tet.2009.02.060 78   12 Cited 12 times in Scopus12 0
Moyle, P. M., Horvath, A., Olive, C., Good, M. F. and Toth, I. (2003) Development of lipid-core-peptide (LCP) based vaccines for the prevention of the group A streptococcal (GAS) infection. Letters In Peptide Science, 10 5-6: 605-613. doi:10.1007/BF02442594 111   4 Cited 7 times in Scopus7 0
Dale, J. B., Batzloff, M., Good, Michael F., McCarthy, J., Carapetis, J. R., Cleary, P. P., Fischettu, V. and Zabriski, J. (2010). Development of vaccines to prevent group A streptococcal infections and rheumatic fever. In Myron M.Levine (Ed.), New generation vaccines 4th ed. (pp. 672-689) New York, U.S.A.: Informa Healthcare. 140 1
Hayman, W. A., Toth, I., Flinn, N., Scanlon, M. and Good, M. F. (2002) Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology. Immunology And Cell Biology, 80 2: 178-187. doi:10.1046/j.1440-1711.2002.01067.x 56   28 Cited 29 times in Scopus29 0
Pender, M. P., Csurhes, P. A., Greer, J. M., Mowat, P. D., Henderson, R. D., Cameron, K. D., McCombe, P. A. and Good, M. F. (1999). Fluctuations in the frequencies of circulating myelin-reactive T cells in healthy subjects and patients with multiple sclerosis. In: 15th Congress of the European Com. for Treatment & Research in Multiple Sclerosis 4th Annual Meeting of America's Com. for Treatment & Research in Multiple Sclerosis. ECTRIMS/ACTRIMS'99, Basel, Switzerland, (S60). 15 - 18 Sept, 1999. 43  
Skwarczynski, Mariusz, Ahmad Fuaad, Abdullah A. H., Rustanti, Lina, Ziora, Zyta M., Aqil, Mohammed, Batzloff, Michael R., Good, Michael F. and Toth, Istvan (2011) Group A streptococcal vaccine candidates based on the conserved conformational epitope from M protein. Drug Delivery Letters, 1 1: 2-8. doi:10.2174/2210304X11101010002 178 2 0
Olive, C., Batzloff, M., Horvath, A., Clair, T., Yarwood, P., Toth, I. and Good, M. F. (2004) Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide construct. Indian Journal of Medical Research, 119 Suppl.: 88-94. 75   12 Cited 11 times in Scopus11
Elliott, Salenna R., Kuns, Rachel D. and Good, Michael F. (2005) Heterologous immunity in the absence of variant-specific antibodies after exposure to subpatent infection with blood-stage malaria. Infection and Immunity, 73 4: 2478-2485. doi:10.1128/IAI.73.4.2478-2485.2005 36   42 Cited 44 times in Scopus44 0
Moyle, P. M., Olive, C., Ho, M.-F., Good, M F and Toth, I (2006). Highly pure, multi-epitopic lipopeptide vaccine delivery system: Synthesis and investigation. In: Brisbane Biological & Organic Chemistry Symposium. Brisbane Biological & Organic Chemistry Symposium, Brisbane, (Abstract). 24 Nov 2006. 53  
Woodberry, Tonia, Pinzon-Charry, Alberto, Piera, Kim A., Panpisutchai, Yawalak, Engwerda, Christian R., Doolan, Denise L., Salwati, Ervi, Kenangalem, Enny, Tjitra, Emiliana, Price, Ric N., Good, Michael F. and Anstey, Nicholas M. (2009) Human T cell recognition of the blood stage antigen Plasmodium hypoxanthine guanine xanthine phosphoribosyl transferase (HGXPRT) in acute malaria. Malaria Journal, 8 122.1-122.10. doi:10.1186/1475-2875-8-122 61   5 Cited 5 times in Scopus5 0
Wipasa, J., Hirunpetcharat, C., Mahakunkijcharoen, Y., Xu, H. J., Elliott, S. and Good, M. F. (2002) Identification of T cell epitopes on the 33-kDa fragment of Plasmodium yoelii merozoite surface protein 1 and their antibody-independent protective role in immunity to blood stage malarial. Journal of Immunology, 169 2: 944-951. 30   32 Cited 33 times in Scopus33
Wipasa, J., Elliott, S., Xu, H. and Good, M. F. (2002) Immunity to asexual blood stage malaria and vaccine approaches. Immunology And Cell Biology, 80 5: 401-414. doi:10.1046/j.1440-1711.2002.01107.x 52   40 Cited 41 times in Scopus41 0
Pombo, David J., Lawrence, Gregor, Hirunpetcharat, Chakrit, Rzepczyk, Christine, Bryden, Michelle, Cloonan, Nicole, Anderson, Karen, Mahakunkijcharoen, Yuvadee, Martin, Laura B., Wilson, Danny, Elliott, Salenna, Elliott, Suzanne, Eisen, Damon P., Weinberg, J. Brice, Saul, Allan and Good, Michael F. (2002) Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. The Lancet, 360 9333: 610-617. doi:10.1016/S0140-6736(02)09784-2 86   228 Cited 231 times in Scopus231 0
Zaman, Mehfuz, Abdel-Aal, Abu-Baker M., Fujita, Yoshio, Phillipps, Karen S. M., Batzloff, Michael R., Good, Michael F. and Toth, Istvan (2012) Immunological evaluation of lipopeptide group A streptococcus (GAS) vaccine: Structure-activity relationship. PLoS One, 7 1: e30146.1-e30146.7. doi:10.1371/journal.pone.0030146 68   12 Cited 15 times in Scopus15 11
Pender, Michael P., Csurhes, Peter A., Wolfe, Nigel P., Hooper, Kaye D., Good, Michael F., McCombe, Pamela A. and Greer, Judith M. (2003) Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis. Journal of Clinical Neuroscience, 10 1: 63-66. doi:10.1016/S0967-5868(02)00270-9 575 458 32 Cited 34 times in Scopus34 0
Greer, J. M., Csurhes, P. A., Cameron, K. D., McCombe, P. A., Good, M. F. and Pender, M. P. (1997) Increased Immunoreactivity to Two Overlapping Peptides of Myelin Proteolipid Protein in Multiple Sclerosis. Brain, 120 8: 1447-1460. doi:10.1093/brain/120.8.1447 178 233 51 Cited 53 times in Scopus53 0
Olive, Colleen, Sun, Hsien Kuo, Ho, Mei‐Fong, Dyer, Joanne, Horvath, Aniko, Toth, Istvan and Good, Michael F. (2006) Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein. Journal of Infectious Diseases, 194 3: 316-324. doi:10.1086/505580 75   25 Cited 29 times in Scopus29 0
Batzloff, Michael R., Hartas, Jon, Zeng, Weiguang, Jackson, David C. and Good, Michael F. (2006) Intranasal vaccination with a lipopeptide containing a conformationally constrained conserved minimal peptide, a universal T cell epitope, and a self-adjuvanting lipid protects mice from group A streptococcus challenge and reduces throat colonization. Journal of Infectious Diseases, 194 3: 325-330. doi:10.1086/505146 62   32 Cited 38 times in Scopus38 0
Edstein, M. D., Kotecka, B. M., Anderson, K. L., Pombo, D. J., Kyle, D. E., Rieckmann, K. H. and Good, M. F. (2005) Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration. Antimicrobial Agents & Chemotherapy, 49 10: 4421-4422. doi:10.1128/AAC.49.10.4421-4422.2005 24   28 Cited 29 times in Scopus29 0
Toth, I., Horvath, A., Blanchfield, J. T., Olive, C., Good, M. F., Wimmer, N. and Rakoczy, E. P. (2003). Lipid and carbohydrate based macromolecules in drug and vaccine delivery. In: Brisbane Biological and Organic Chemistry Symposium, Gold Coast, (). 28 November, 2003. 57  
Toth, I., Horvath, A., McGeary, R. P., Hayman, W. A., Olive, C. and Good, M. F. (2002). Lipid-core-peptides for vaccination: Structure-activity relationship. In: E. Benedetti and C. Pedone, Peptides 2002. 27th European Peptide Symposium, Sorrento, Italy, (634-635). 31 Aug. - 6 Sept. 2002. 53  
Horvath, Aniko, Olive, Colleen, Wong, Allan, Clair, Timothy, Yarwood, Penny, Good, Michael and Toth, Istvan (2002) Lipoamino acid-based adjuvant carrier system: Enhanced immunogenicity of group a streptococcal peptide epitopes. Journal of Medicinal Chemistry, 45 6: 1387-1390. doi:10.1021/jm0110441 49   22 Cited 24 times in Scopus24 0
Toth, I., Moyle, P. M., Koda, Y., Olive, C. and Good, M. F. (2006). Liposaccharides in peptide, gene and vaccine delivery. In: 33rd Annual Meeting & Exposition of the Controlled Release Society. 33rd Annual Meeting and Exposition of the Controlled Release Soy, Vienna, (Abstract). 22-26 July, 2006. 49  
Toth, I., Moyle, P. M., Simerska, P., Fujita, Y., Olive, C. and Good, M. F. (2006). Liposaccharides in peptide, gene and vaccine delivery. In: Proceedings of Drug Design Amongst the Vines. Drug Design Amongst the Vines, Hunter Valley, (Abstract). 3 - 7 December, 2006. 48  
Toth, I, Moyle, P. M., Koda, Y., Olive, C. and Good, M F (2006). Liposaccharides in peptide, gene and vaccine delivery. In: 10th Naples Workshop on Bioactive Peptides. 10th Naples Workshop on Bioactive Peptides, Naples, (Abstract). 11-14 June, 2006. 55  
Simerska, P., Moyle, P. M., Abdel-Aal, A. M., Fujita, Y., Olive, C., Batzloff, M. R., Good, M. F. and Toth, I. (2007). Liposaccharides in Peptide Vaccine Delivery. In: Jackie Wilce, Proceedings of the 4th International Peptide Symposium in conjunction with the 7th Australian Peptide Conference and the 2nd Asia-Pacific International Peptide Symposium, 2007. 4th International Peptide Symposium, Cairns, (1-2). 21-25 October 2007. 105  
Hirunpetcharat, C., Finkleman, F., Clark, I. A. and Good, M. F. (1999) Malaria parasite specific TH1-like T cells simultaneously reduce parasitemia & promote disease. Parasite Immunology, 21 6: 319-329. doi:10.1046/j.1365-3024.1999.00234.x 34   34 Cited 38 times in Scopus38 0
Jones, Malcolm K. and Good, Michael F. (2006) Malaria parasites up close. Nature Medicine, 12 2: 170-171. doi:10.1038/nm0206-170 52   3 Cited 4 times in Scopus4 0
Good, Michael F. and Doolan, Denise L. (2010) Malaria vaccine design: Immunological Considerations. Immunity, 33 4: 555-566. doi:10.1016/j.immuni.2010.10.005 29   45 Cited 48 times in Scopus48 0
Wykes, M. and Good, M. F. (2006) Memory B cell responses and malaria. Parasite Immunology, 28 1-2: 31-34. doi:10.1111/j.1365-3024.2006.00768.x 18   14 Cited 14 times in Scopus14 0
Moyle, P. M., Olive, C., Ho, M. F., Burgess, M., Karpati, L., Good, M. F. and Toth, I. (2006) Method for the Synthesis of Multi-Epitopic Streptococcus pyogenes Lipopeptide Vaccines Using Native Chemical Ligation. Journal of Organic Chemistry, 71 18: 6846-6850. doi:10.1021/jo060960p 67   14 Cited 13 times in Scopus13 0
Skwarczynski, Mariusz, Kamaruzaman, Khairul A., Srinivasan, Saranya, Zaman, Mehfuz, Lin, I-Chun, Batzloff, Michael R., Good, Michael F. and Toth, Istvan (2013) M-protein-derived conformational peptide epitope vaccine candidate against Group A Streptococcus. Current Drug Delivery, 10 1: 39-45. doi:10.2174/1567201811310010007 92   5 Cited 5 times in Scopus5 0
Fujita, Y, Moyle, P. M., Olive, C., Good, M F and Toth, I (2006). Multi-epitopic lipid core peptide vaccine with broad protective immune responses against Group A streptococcus. In: 29th European Peptide Symposium. 29th European Peptide Symposium, Gdansk, (Abstract). 3-8 Sept, 2006. 53  
Wipasa, Jiraprapa, Xu, Huji, Makobongo, Morris, Gatton, Michelle, Stowers, Anthony and Good, Michael F. (2002) Nature and specificity of the required protective immune response that develops postchallenge in mice vaccinated with the 19-kilodalton fragment of Plasmodium yoelii merozoite surface protein 1. Infection And Immunity, 70 11: 6013-6020. doi:10.1128/IAI.70.11.6013-6020.2002 48   14 Cited 14 times in Scopus14 0
Simerska, P., Abdel-Aal, A. B., McGeary, R., Moyle, P.M., Fujita, Y., Good, M.F. and Toth, I. (2007). Peptide-lipid-carbohydrate based vaccine against group A Streptococcal infection.. In: International Proceedings of the 13th International Congress of Immunology. 13th International Congress of Immunology, Rio de Janeiro, Brazil, (). August 21-25. 33  

Page 1 of 2

Result Pages:    1 2  next › last »